BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 3259478)

  • 1. Stimulation of the growth of azaserine-induced nodules in the rat pancreas by dietary camostate (FOY-305).
    Lhoste EF; Roebuck BD; Longnecker DS
    Carcinogenesis; 1988 Jun; 9(6):901-6. PubMed ID: 3259478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas.
    Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB
    Cancer Res; 1989 May; 49(9):2438-41. PubMed ID: 2706631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of L-364,718, a new cholecystokinin receptor antagonist, on camostate-induced growth of the rat pancreas.
    Wisner JR; McLaughlin RE; Rich KA; Ozawa S; Renner IG
    Gastroenterology; 1988 Jan; 94(1):109-13. PubMed ID: 3335282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the synthetic trypsin inhibitor camostate on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters.
    Meijers M; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA
    Cancer Lett; 1991 Dec; 60(3):205-11. PubMed ID: 1756510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of corn oil and benzyl acetate on number and size of azaserine-induced foci in the pancreas of LEW and F344 rats.
    Longnecker DS; Roebuck BD; Curphey TJ; Lhoste E; Coon CI; MacMillan D
    Environ Health Perspect; 1986 Sep; 68():197-201. PubMed ID: 3490965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine inhibition of azaserine-induced atypical acinar cell foci in rat pancreas.
    Shinozuka H; Roebuck BD; Longnecker DS
    Pancreas; 1990 Jul; 5(4):389-93. PubMed ID: 2381899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of estrogen and castration on the early stage of pancreatic carcinogenesis in Fischer rats treated with azaserine.
    Sumi C; Longnecker DS; Roebuck BD; Brinck-Johnsen T
    Cancer Res; 1989 May; 49(9):2332-6. PubMed ID: 2706621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
    Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH
    Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of synthetic protease inhibitor camostate on pancreatic exocrine function in rats.
    Otsuki M; Ohki A; Okabayashi Y; Suehiro I; Baba S
    Pancreas; 1987; 2(2):164-9. PubMed ID: 3628222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-alpha and epidermal growth factor expression in the exocrine pancreas of azaserine-treated rats: modulation by cholecystokinin or a low fat, high fiber (caloric restricted) diet.
    Visser CJ; Woutersen RA; Bruggink AH; van Garderen-Hoetmer A; Seifert-Bock I; Tilanus MG; de Weger RA
    Carcinogenesis; 1995 Sep; 16(9):2075-82. PubMed ID: 7554057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased CCK-response to proteinase inhibitor feeding after induction of pancreatic hypertrophy in rats.
    Göke B; Fenchel K; Knobloch S; Arnold R; Adler G
    Pancreas; 1988; 3(5):576-9. PubMed ID: 3186685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
    Niederau C; Liddle RA; Williams JA; Grendell JH
    Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of camostate administration for two weeks on experimental pancreatitis in mice and rats.
    Leonhardt U; Seidensticker F; Stöckmann F; Creutzfeldt W
    Pancreas; 1993 Jan; 8(1):98-102. PubMed ID: 7678329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dietary fats and soybean protein on azaserine-induced pancreatic carcinogenesis and plasma cholecystokinin in the rat.
    Roebuck BD; Kaplita PV; Edwards BR; Praissman M
    Cancer Res; 1987 Mar; 47(5):1333-8. PubMed ID: 3815341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of trypsin inhibitor (camostate) on pancreas and CCK release in young and old female rats.
    Miyasaka K; Nakamura R; Kitani K
    J Gerontol; 1989 Jul; 44(4):M136-40. PubMed ID: 2738309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a specific serine protease inhibitor on the rat pancreas: systemic administration of camostate and exocrine pancreatic secretion.
    Göke B; Stöckmann F; Müller R; Lankisch PG; Creutzfeldt W
    Digestion; 1984; 30(3):171-8. PubMed ID: 6209186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of induction and growth of putative precancerous acinar cell foci in azaserine-induced rat pancreas carcinogenesis.
    Bax J; Schippers-Gillissen C; Woutersen RA; Scherer E
    Carcinogenesis; 1990 Feb; 11(2):245-50. PubMed ID: 2137381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous administration of the synthetic trypsin inhibitor Foy-305 induces hypertrophy of the exocrine pancreas.
    Wereszczyńska-Siemiatkowska U; Pohl U; Otto J; Lankisch PG
    Digestion; 1987; 37(3):144-8. PubMed ID: 2443410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long-term CCK stimulation and CCK blockade on pancreatic and intestinal growth, morphology, and function.
    Niederau C; Lüthen R; Niederau M; Strohmeyer G; Ferrell LD; Grendell JH
    Digestion; 1990; 46 Suppl 2():217-25. PubMed ID: 2262055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of two populations of pancreatic atypical acinar cell foci induced by azaserine in the rat.
    Roebuck BD; Baumgartner KJ; Thron CD
    Lab Invest; 1984 Feb; 50(2):141-6. PubMed ID: 6694355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.